Neurology and Multiple Sclerosis
Ferraz Lynce Especialidades Farmaceuticas S.A. is involved in clinical research focused on multiple sclerosis, with attention to the neurological burden associated with the disease and its impact on daily functioning.
- Multiple sclerosis care
- Neurological symptoms
- Central nervous system disorders
The sponsor’s research activity is centered on a single therapeutic area within neurology, reflecting interest in conditions where symptom control remains a major clinical need.
Chronic Neuropathic Pain
The sponsor’s clinical research includes chronic neuropathic pain, particularly pain linked to multiple sclerosis, with a focus on persistent sensory discomfort and its treatment.
- Neuropathic pain
- Chronic pain management
- Pain relief
This area reflects a therapeutic interest in pain syndromes that are difficult to manage and often require targeted symptom-focused interventions.
Cannabinoid-Based Therapy
Clinical activity funded by the sponsor includes research into cannabinoid-based therapy, with examination of THC and CBD as therapeutic agents for neurological pain conditions.
- Tetrahydrocannabinol (THC)
- Cannabidiol (CBD)
- Oral cannabinoid formulations
The research interest is directed toward treatment approaches that use cannabinoid compounds in the management of symptoms associated with multiple sclerosis.
Symptom Control in Neurological Disease
The sponsor’s trial portfolio addresses symptom control in neurological disease, concentrating on the relief of pain-related manifestations rather than broader disease modification.
- Symptomatic treatment
- Quality-of-life related symptoms
- Refractory pain conditions
This therapeutic domain connects pain medicine with neurology, especially where persistent symptoms remain a key treatment challenge.
